Natural Product: NPC326627

Natural Product IDNPC326627
Common Name
?
The InCHIKey will be temporarily assigned as the "Common Name" if no IUPAC name or alternative short name is available.
17-Hydroxy-17-(2-Hydroxyacetyl)-10,13-Dimethyl-2,6,7,8,9,11,12,14,15,16-Decahydro-1H-Cyclopenta[A]Phenanthren-3-One
IUPAC Name 17-hydroxy-17-(2-hydroxyacetyl)-10,13-dimethyl-2,6,7,8,9,11,12,14,15,16-decahydro-1H-cyclopenta[a]phenanthren-3-one
Synonyms
Synthetic Gene Cluster n.a.
ChEMBL Identifier CHEMBL1705958
PubChem CID 227112
Chemical Classification
  • CHEMONTID:0000000 [Organic compounds]
    • [CHEMONTID:0000012] Lipids and lipid-like molecules
      • [CHEMONTID:0000258] Steroids and steroid derivatives
        • [CHEMONTID:0001295] Hydroxysteroids
          • [CHEMONTID:0003095] 21-hydroxysteroids

The Chemical Classification was calculated by Classyfire, a software for chemical taxonomy calculation. Reference: DOI:10.1186/s13321-016-0174-y.

  Chemical Representations

Standard InCHIKey WHBHBVVOGNECLV-UHFFFAOYSA-N
Standard InCHI InChI=1S/C21H30O4/c1-19-8-5-14(23)11-13(19)3-4-15-16(19)6-9-20(2)17(15)7-10-21(20,25)18(24)12-22/h11,15-17,22,25H,3-10,12H2,1-2H3
SMILES CC12CCC(=O)C=C1CCC3C2CCC4(C3CCC4(C(=O)CO)O)C

  Calculated Properties

Physi-Chem Properties

Molecular Weight:   346.21 Volume:   364.798
?
Van der Waals volume.
Dense:   0.949 LogP:   2.541
?
The logarithm of the n-octanol/water distribution coefficients.
logD7.4:   2.733
?
The logarithm of the n-octanol/water distribution coefficient at pH=7.4.
LogS:   -4.139
?
The logarithm of aqueous solubility value.
Rotatable Bonds:   2.0 Rigid Bonds:   22.0
TPSA:   74.6
?
Topological Polar Surface Area.
H-Bond Acceptor:   4.0
H-Bond Donor:   2.0 Rings:   4.0
Heavy Atoms:   4.0

MedChem Properties

QED Drug-Likeness Score:   0.806 GASA:   0.0
?
GASA represents the probability of being difficult to synthesize, ranging from 0 to 1.
Synthetic Accessibility Score:   4.128 Fsp3:   0.81
MCE-18:   73.895
?
MCE-18 stands for medicinal chemistry evolution.MCE-18≥45 is considered a suitable value.
Lipinski Rule-of-5:   Rejected
Pfizer Rule:   Rejected GSK Rule:   Rejected
Golden Triangle Rule:   Rejected BMS Rule:   0
Chelating Alert:   0 PAINS Alert:   0
Colloidal aggregators:   0.006 Fluc inhibitor:   0.0
?
The fluc inhibitor value is the probability of being fLuc inhibitors, within the range of 0 to 1.
Blue fluorescence:   0.003
?
The blue fluorescence value is the probability of being blue fluorescence, within the range of 0 to 1
Green fluorescence:   0.034
?
The green fluorescence value is the probability of being green fluorescence, within the range of 0 to 1
Reactive compounds:   0.342 Promiscuous compounds:   0.356

ADMET Properties (ADMETlab3.0)

ADMET: Absorption

Caco-2 Permeability:   -4.294 MDCK Permeability:   -4.78
Pgp-inhibitor:   0.25 Pgp-substrate:   0.019
PAMPA:   0.087
?
The experimental data for Peff was logarithmically transformed (logPeff). Molecules with log Peff values below 2.0 were classified as low-permeability (Category 0), while those with log Peff values exceeding 2.5 were classified as high-permeability (Category 1).
Human Intestinal Absorption (HIA):   0.003
20% Bioavailability (F20%):   0.016 30% Bioavailability (F30%):   0.016
50% Bioavailability (F50%):   0.133

ADMET: Distribution

Blood-Brain-Barrier Penetration (BBB):   0.565 MRP1:   0.984
Plasma Protein Binding (PPB):   84.798% Volume Distribution (VD):   -0.345
Fu: 8.991%
?
The fraction unbound in plasms.
OATP1B1 inhibitor:   0.001
OATP1B3 inhibitor:   0.025 BCRP inhibitor:   0.006
BSEP inhibitor:   0.991

ADMET: Metabolism

CYP1A2-inhibitor:   0.375 CYP1A2-substrate:   0.0
CYP2C19-inhibitor:   0.998 CYP2C19-substrate:   0.0
CYP2C9-inhibitor:   0.827 CYP2C9-substrate:   0.0
CYP2D6-inhibitor:   0.0 CYP2D6-substrate:   0.0
CYP3A4-inhibitor:   1.0 CYP3A4-substrate:   0.0
CYP2B6-substrate:   0.017 CYP2C8-inhibitor:   0.452
HLM stability:   0.904
?
Human liver microsomal (HLM) stability. Category 0: stable+ (HLM > 30 min); Category 1: unstable- (HLM ≤ 30 min). The output value is the probability of human liver microsomal instability, where a value closer to 1 indicates a higher likelihood of instability.

ADMET: Excretion

Clearance (CL):  4.97 Half-life (T1/2):  2.252

ADMET: Toxicity

hERG Blockers:  0.075 hERG Blockers (10um):  0.271
Human Hepatotoxicity (H-HT):  0.757 Drug-induced Liver Injury (DILI):  0.102
AMES Toxicity:  0.212 Rat Oral Acute Toxicity:  0.11
Maximum Recommended Daily Dose:  0.737 Skin Sensitization:  0.036
Carcinogencity:  0.665 Eye Corrosion:  0.0
Eye Irritation:  0.063 Respiratory Toxicity:  0.345
Drug-induced Neurotoxicity:  0.194 Ototoxicity:  0.842
Hematotoxicity:  0.261 Drug-induced Nephrotoxicity:  0.059
Genotoxicity:  0.164 RPMI-8226 Immunitoxicity:  0.049
A549 Cytotoxicity:  0.043 Hek293 Cytotoxicity:  0.292
BCF:   0.814
?
Bioconcentration factors are used for considering secondary poisoning potential and assessing risks to human health via the food chain. The unit is -log10[(mg/L)/(1000*MW)].
IGC50:   3.788
?
48 hour Tetrahymena pyriformis IGC50. The unit of IGC50 is -log10[(mg/L)/(1000*MW)].
LC50DM:   5.447
?
48 hour Daphnia magna LC50. The unit of LC50DM is -log10[(mg/L)/(1000*MW)].
LC50FM:   4.446
?
96 hour fathead minnow LC50. The unit of LC50FM is -log10[(mg/L)/(1000*MW)].

  Species Source

Organism ID Organism Name Taxonomy Level Family SuperKingdom Isolation Part Collection Location Collection Time Reference
NPO30940 Bas taurus n.a. n.a. n.a. n.a. n.a. n.a. Database[TCM_Taiwan]

Note for Reference:
In addition to directly collecting NP source organism data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated them from below databases:
UNPD: Universal Natural Products Database [PMID: 23638153].
StreptomeDB: a database of streptomycetes natural products [PMID: 33051671].
TM-MC: a database of medicinal materials and chemical compounds in Northeast Asian traditional medicine [PMID: 26156871].
TCM@Taiwan: a Traditional Chinese Medicine database [PMID: 21253603].
TCMID: a Traditional Chinese Medicine database [PMID: 29106634].
TCMSP: The traditional Chinese medicine systems pharmacology database and analysis platform [PMID: 24735618].
HerDing: a herb recommendation system to treat diseases using genes and chemicals [PMID: 26980517].
MetaboLights: a metabolomics database [PMID: 27010336].
FooDB: a database of constituents, chemistry and biology of food species [www.foodb.ca].



  NP Quantity Composition/Concentration

Organism ID Organism Name Organism Material Preparation Organism Part NP Quantity (Standard) NP Quantity (Minimum) NP Quantity (Maximum) Quantity Unit Reference

Note for Reference:
In addition to directly collecting NP quantitative data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated NP quantitative records for specific NP domains (e.g., NPS from foods or herbs) from domain-specific databases. These databases include:
DUKE: Dr. Duke's Phytochemical and Ethnobotanical Databases.
PHENOL EXPLORER: is the first comprehensive database on polyphenol content in foods [PMID: 24103452], its homepage can be accessed at here.
FooDB: a database of constituents, chemistry and biology of food species [www.foodb.ca].



 Biological Activity

Molecular-level activity

Target ID Target Type Target Name Target Organism Activity Type Activity Relation Value Unit Reference
NPT152 Individual protein Nuclear factor erythroid 2-related factor 2 Homo sapiens Potency n.a. 6513.1 nM PubChem BioAssay data set
NPT135 Individual protein Chromobox protein homolog 1 Homo sapiens Potency n.a. 79432.8 nM PubChem BioAssay data set
NPT10 Individual protein Geminin Homo sapiens Potency n.a. 115.8 nM PubChem BioAssay data set
NPT160 Individual protein TAR DNA-binding protein 43 Homo sapiens Potency n.a. 354.8 nM PubChem BioAssay data set

In vitro activity

Target ID Target Type Target Name Target Organism Activity Type Activity Relation Value Unit Reference
NPT20 Organism Candida albicans Candida albicans Inhibition = 3.12 % DOI[10.6019/CHEMBL4513141]
NPT173 Organism Klebsiella pneumoniae Klebsiella pneumoniae Inhibition = 8.14 % DOI[10.6019/CHEMBL4513141]
NPT19 Organism Escherichia coli Escherichia coli Inhibition = -7.68 % DOI[10.6019/CHEMBL4513141]
NPT18 Organism Pseudomonas aeruginosa Pseudomonas aeruginosa Inhibition = 7.63 % DOI[10.6019/CHEMBL4513141]
NPT747 Organism Acinetobacter baumannii Acinetobacter baumannii Inhibition = 14.88 % DOI[10.6019/CHEMBL4513141]

In vivo activity

Target ID Target Type Target Name Target Organism Activity Type Activity Relation Value Unit Reference





 Experimental ADME

Experiment Model Experiment Tissue ADME Type ADME Relation ADME Value ADME Unit Reference





 Experimental Toxicity

Quantitative toxicity

Experiment Model Experiment Organism Toxicity Type Toxicity Relation Toxicity Value Toxicity Unit Reference

Common Abbreviations:
LC: Lethal Concentration; LD: Lethal Dose; LT:Lethal Time; NOAEL: No-observed-adverse-effect Level; BMDL: Benchmark Dose Lower Confidence Limit; BMD: Benchmark Dose; BMC:Benchmark Concentration; LOAEL: Lowest Observed Adverse Effect Level; RfD:Reference Dose; RfC:Reference Concentration; MRL: Minimal Risk Level; MEG: Maximum Exposure Guideline; PAC: Protective Action Criteria

Categorical toxicity labels

Hepatotoxicity Carcinogenicity Mutagenicity Cardiotoxicity Respiratory Toxicity Eye Irritation Endocrine Disruption
Hepatotoxicity Carcinogenicity Mutagenicity Cardiotoxicity Respiratory Toxicity Eye Irritation Endocrine Disruption

Note for Reference:
In addition to directly collecting NP quantitative data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated NP toxicity records from domain-specific databases. These databases include:
ToxValDB: a curated database that compiles quantitative toxicity values for chemicals from diverse public sources to support toxicological research and risk assessment.
TOXRIC: a comprehensive, free-to-access, online database providing toxicological/feature data. The toxicity labels are retrieved from this database. [PMID: 36400569]


  Chemically structural similarity

Similar Active Natural Products in NPASS

Top-200 similar NPs were calculated against the active-NP-set (includes approximately 50,000 NPs with experimentally-derived bioactivity available in NPASS)

Similarity is measured using the Tanimoto coefficient (Tc) , which compares the binary fingerprints of two molecules. Tc is calculated as the intersection divided by the union of '1' bits in the fingerprints, ranging from 0 to 1, with 1 indicating highest similarity.

●  The left chart: Distribution of similarity level between NPC326627 and all remaining natural products in the NPASS database.
●  The right table: Most similar natural products (Tc>=0.5 or Top200).

Similarity Score Similarity Level Natural Product ID
1.0 High Similarity NPC310010
0.8571 High Similarity NPC144258
0.7455 Intermediate Similarity NPC233118
0.7321 Intermediate Similarity NPC18509
0.7321 Intermediate Similarity NPC319582
0.614 Remote Similarity NPC237712
0.5789 Remote Similarity NPC214043
0.5789 Remote Similarity NPC227064
0.5789 Remote Similarity NPC85774
0.5789 Remote Similarity NPC329043
0.5789 Remote Similarity NPC58841
0.5789 Remote Similarity NPC161423
0.569 Remote Similarity NPC327115
0.5636 Remote Similarity NPC139397
0.5536 Remote Similarity NPC307176
0.5536 Remote Similarity NPC321874
0.5439 Remote Similarity NPC2634
0.5439 Remote Similarity NPC265782
0.5439 Remote Similarity NPC251929
0.5424 Remote Similarity NPC115023
0.5333 Remote Similarity NPC149203
0.5254 Remote Similarity NPC282593
0.5217 Remote Similarity NPC478926
0.5167 Remote Similarity NPC35734
0.5167 Remote Similarity NPC159577
0.5167 Remote Similarity NPC602429
0.5156 Remote Similarity NPC334061

Similar Clinical/Approved Drugs

Similarity level is defined by Tanimoto coefficient (Tc) between two molecules.

●  The left chart: Distribution of similarity level between NPC326627 and all drugs/candidates.
●  The right table: Most similar clinical/approved drugs (Tc>=0.5 or Top200).

Similarity Score Similarity Level Drug ID Developmental Stage
1.0 High Similarity NPD4753 Phase 2
0.7647 Intermediate Similarity NPD4221 Phase 4
0.7321 Intermediate Similarity NPD4754 Approved
0.7321 Intermediate Similarity NPD4755 Phase 4
0.7222 Intermediate Similarity NPD4693 Phase 3
0.5965 Remote Similarity NPD4197 Pre-clinical
0.5862 Remote Similarity NPD5329 Approved
0.5789 Remote Similarity NPD3666 Phase 4
0.5536 Remote Similarity NPD4747 Phase 4
0.5469 Remote Similarity NPD6083 Phase 4
0.5469 Remote Similarity NPD6084 Phase 2
0.5455 Remote Similarity NPD5696 Phase 4
0.5455 Remote Similarity NPD5739 Phase 4
0.5439 Remote Similarity NPD4691 Approved
0.5303 Remote Similarity NPD4700 Phase 2
0.5294 Remote Similarity NPD4767 Approved
0.5254 Remote Similarity NPD4223 Phase 3
0.5217 Remote Similarity NPD4768 Phase 4
0.5156 Remote Similarity NPD4629 Phase 4
0.5156 Remote Similarity NPD4696 Phase 4
0.5082 Remote Similarity NPD5280 Approved

Bioactivity similarity

  Bioactivity similarity

Similar Natural Products in NPASS

Similarity level is defined by Bioactivity similarity was calculated based on bioactivity descriptors of compounds. The bioactivity descriptors were calculated by a recently developed AI algorithm Chemical Checker (CC) [Nature Biotechnology, 38:1087–1096, 2020; Nature Communications, 12:3932, 2021], which evaluated bioactivity similarities at five levels:
A: chemistry similarity;
B: biological targets similarity;
C: networks similarity;
D: cell-based bioactivity similarity;
E: similarity based on clinical data.
Those 5 categories of CC bioactivity descriptors were calculated and then subjected to manifold projection using UMAP algorithm, to project all NPs on a 2-Dimensional space. The current NP was highlighted with a small circle in the 2-D map. Below figures: left-to-right, A-to-E.

A: chemistry similarity
B: biological targets similarity
C: networks similarity
D: cell-based bioactivity similarity
E: similarity based on clinical data